Description

The company’s proprietary technologies enable the harvesting and chemical deconvolution of sufficient quantities of unstudied aquatic microorganisms to unlock the enormous novel chemical diversity found in the environment. This chemistry is captured in simplified samples for screening in state-of-the-art assays against critical diseases. Their primary compound pipeline includes: Cancer, Autoimmune, and Cardiovascular.

Posted Oct 24, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.